Botox vs. Jeuveau: The Comparison Guide

Reviewed for medical accuracy against our Medical Review Board  ·  Last updated 15 August 2026

Built for cosmetic use only and priced to compete. What that actually buys you.

A gloved hand holding four prepared syringes fanned out against a pink background
Jeuveau is licensed for cosmetic use only, which is the cleanest distinction between it and Botox.

In the ever-evolving world of aesthetic medicine, Botox remains a household name, but Jeuveau has recently entered the spotlight with promises of affordability, fast onset, and results comparable to the gold standard. Whether you're new to neuromodulators or a seasoned user curious about switching, this guide provides an exhaustive comparison.

We’ll dive deep into how each neurotoxin works, their FDA approvals, molecular structure, clinical results, user experiences, off-label use, pricing, safety, and more. By the end, you'll have every detail needed to confidently choose the injectable that’s right for you.


1. Two different treatments: Botox and Jeuveau

1.1 Definitions and Origins

Botox (OnabotulinumtoxinA): The original botulinum toxin type A product, approved in 1989 for medical use and in 2002 for cosmetic purposes. Developed by Allergan, it has since become the most widely used neuromodulator globally.

Jeuveau (PrabotulinumtoxinA-xvfs): Released in 2019 by Evolus, Jeuveau is manufactured exclusively for aesthetic use and produced in South Korea using a unique Hi-Pure technology. It is FDA-approved for treating glabellar lines.

1.2 Mechanism of Action

Both Botox and Jeuveau work by inhibiting the release of acetylcholine, a neurotransmitter responsible for muscle contraction. When injected into specific muscles, they temporarily paralyze the area, smoothing out dynamic wrinkles caused by facial expressions.

1.3 FDA Approval and Global Use

Botox:

  • Approved for over 10 medical and cosmetic indications
  • Used in over 90 countries
  • Trusted for both aesthetic and therapeutic use

Jeuveau:

  • FDA-approved only for glabellar lines
  • Marketed in the U.S., Canada, and select global markets
  • Not approved for any medical indications

1.4 Formulation and Manufacturing

Botox:

  • Manufactured in Ireland
  • Contains protective proteins around the active neurotoxin
  • Stable and extensively studied formula

Jeuveau:

  • Produced in South Korea with Hi-Pure technology
  • Claims higher purity and reduced risk of antibody formation
  • Marketed toward millennials and cosmetic-first users

2. Where Botox and Jeuveau genuinely differ

2.A Molecular Structure & Stability

  • Both use botulinum toxin type A, but Jeuveau has a smaller complexing protein structure.
  • Jeuveau’s high-purity claim may reduce antibody resistance (though rare for both products).

2.B Official Indications

2.C Diffusion and Spread

Clinical anecdotal evidence suggests:

  • Botox: More precise diffusion, often chosen for smaller or delicate areas.
  • Jeuveau: Slightly broader spread, preferred for larger areas by some injectors.

2.D Unit Conversion and Dosing Guidelines

  • Botox and Jeuveau are generally interchangeable on a 1:1 unit basis.
  • However, injector technique and brand familiarity impact outcomes significantly.

2.E Shelf Life and Storage

  • Botox: Must be refrigerated before and after reconstitution; stable post-mixing for 24 hours (some use longer).
  • Jeuveau: Similar storage requirements, though some practitioners note better stability post-mix.

3. Results compared

3.A Onset of Action

  • Botox: Results begin in 3–5 days, peak at 10–14 days.
  • Jeuveau: Some users report results within 2–3 days, possibly peaking sooner.

3.B Duration of Effects

  • Botox: Lasts 3–4 months for most patients.
  • Jeuveau: Lasts 3–4 months as well, with some anecdotal reports of shorter or equal duration.

Clinical trials show equivalency in outcomes, though subtle differences exist in metabolization.

3.C Aesthetic Outcomes

  • Both produce natural results when administered correctly.
  • Jeuveau is often marketed as giving a "softer," more youthful look.

3.D Efficacy for Various Facial Areas

AreaBotox ApprovedJeuveau ApprovedReal-World Use (Jeuveau)
Glabellar Lines
Crow’s Feet✅ (off-label)
Forehead Lines✅ (off-label)
Bunny Lines✅ (off-label)
Lip Lines✅ (off-label)

4. The real cost of each

4.A Cost Per Unit (U.S. Market)

  • Botox: $12–$20/unit
  • Jeuveau: $8–$16/unit

4.B Total Treatment Cost

AreaBotox (avg.)Jeuveau (avg.)
Glabellar Lines$250–$500$200–$400
Forehead Lines$200–$350$180–$300
Crow’s Feet$250–$400$200–$350

4.C Loyalty and Rewards Programs

  • Botox: Allē by AbbVie, points-based loyalty with bundled services
  • Jeuveau: Evolus Rewards, instant rebates and occasional promos

4.D Insurance Coverage

  • Botox’s medical uses may be covered by insurance
  • Jeuveau is cosmetic-only; not covered by any insurance plan

5. Risks worth knowing about

5.A Common Side Effects (Both)

  • Injection site redness
  • Swelling or tenderness
  • Bruising
  • Headache

5.B Rare Side Effects

  • Ptosis (eyelid drooping)
  • Facial asymmetry
  • Flu-like symptoms
  • Difficulty swallowing or breathing (extremely rare)

5.C Risk of Antibody Formation

  • Rare but possible with frequent treatments
  • Jeuveau claims reduced risk due to higher purity
  • Botox’s long-term studies show low immunogenicity with recommended dosing

6. Ideal Candidates: Who Should Choose Which?

Botox Is Best For:

  • Patients needing treatment for migraines, hyperhidrosis, TMJ
  • Individuals who want decades of safety data
  • People who prefer a conservative approach

Jeuveau Is Best For:

  • Younger patients new to injectables
  • Budget-conscious users seeking purely cosmetic effects
  • Those wanting to experiment with newer options

Patient Considerations

  • Metabolism rate (faster metabolizers may prefer Jeuveau's speed)
  • Skin thickness and muscle structure
  • Previous response to neurotoxins

7. Real-World Experience & Expert Opinions

7.1 What Injectors Say

  • Botox is known for consistency and reliability
  • Jeuveau is praised for affordability and fast results
  • Many top injectors use both depending on client goals

7.2 What the results look like

  • Minimal visible difference in wrinkle reduction when administered properly
  • Results depend far more on injector experience than on brand

8. Switching Between Botox and Jeuveau

8.1 Is It Safe to Switch?

Yes. If you've built resistance or want to test longevity or affordability, switching is common. Wait until the previous treatment fully wears off.

8.2 Can You Mix Them?

It’s not recommended within the same session or facial zone. However, some clinics may use Botox for medical areas and Jeuveau for cosmetic treatment zones.

8.3 Transition Tips

  • Document your prior treatment dates and dosages
  • Observe onset and longevity after your first Jeuveau session
  • Give your body time to adjust and respond

9. Medical Applications: Botox’s Unique Advantage

ConditionBotox ApprovedJeuveau Approved
Chronic Migraines
Hyperhidrosis
Overactive Bladder
TMJ & BruxismOff-label
Facial Spasms

Only Botox is approved for, and widely used in, non-cosmetic medical conditions. Jeuveau has no clinical trials or approvals in these domains.


10. Decision Guide: Botox or Jeuveau?

10.1 What to Consider

  • Goal: Cosmetic only or both cosmetic and medical?
  • Budget: Are you seeking a lower-cost option?
  • Risk Tolerance: Do you prefer a brand with a long history or are you open to newer options?
  • Injector Availability: Does your provider carry both?

10.2 Consultation Checklist

  • Ask your injector about their experience with both products
  • Request a comparison of before-and-after results
  • Discuss pricing, longevity, and potential side effects

10.3 Choosing a Qualified Provider


Final Thoughts: Botox vs. Jeuveau

Botox continues to dominate the neuromodulator market with its unmatched medical credentials, longevity, and safety data. Jeuveau, however, offers a refreshing, modern, and budget-friendly option for purely cosmetic treatments.

If you're seeking the most trusted and versatile solution, Botox is hard to beat.

If you're younger, cost-conscious, and focused solely on wrinkle reduction, Jeuveau could be your new go-to.

In the end, the right choice is personal, and best made in collaboration with a skilled injector who can tailor the treatment to your facial anatomy, history, and goals.


Lucas Pradella, founder of BestBotoxClinics.com

Written by

Lucas Pradella

Founder & Lead Researcher, BestBotoxClinics.com

Lucas founded BestBotoxClinics.com to bring clarity to the aesthetics industry, bringing 13+ years of experience in digital research and analysing online data for signals of quality and trust. He is not a physician, his work is research, data analysis and verifying provider credentials.

Medical accuracy: BestBotoxClinics.com maintains a Medical Review Board of licensed clinicians. This article is educational and is not medical advice.

Same dose, one quarter of the approvals

Read both labels side by side and the comparison gets much simpler than the marketing suggests.

In the one area they share, the drugs are dosed identically. Jeuveau's label and BOTOX Cosmetic's label both specify 4 Units into each of five sites for glabellar lines, 20 Units in total. There is no unit conversion to do, unlike Dysport.

What differs is what else each is allowed to treat. BOTOX Cosmetic holds four cosmetic indications: glabellar lines, lateral canthal lines (crow's feet), forehead lines, and platysma bands, which joined the label in October 2024. Jeuveau holds one, glabellar lines, on a label effective 28 April 2023.

That matters practically rather than academically. If you want your frown lines treated, this is a genuine choice between two comparably dosed drugs. If you want your forehead, your crow's feet or your neck treated, only one of them carries an approval for it, and the other would be off-label. Jeuveau's generic name is prabotulinumtoxinA, and it is the same molecule sold in Korea as Nabota, which our Nabota comparison covers.

Frequently asked questions

Does Jeuveau cause more headaches than Botox?

Its own trial gives no evidence that it causes headaches at all. The Jeuveau label reports headache in 12% of the 492 people who received it and 13% of the 162 who received placebo, so it was marginally more common among people given no drug. The reaction the trials do attribute to Jeuveau is eyelid ptosis, at 2% against 0% on placebo. Any page quoting the 12% without the placebo column beside it is telling you the opposite of what the data says.

Is Jeuveau approved for the same areas as Botox?

No, and this is the largest practical difference between them. Botox Cosmetic holds approvals for four cosmetic areas plus a long list of medical indications. Jeuveau is approved for glabellar lines and nothing else, and its boxed warning states outright that it is not approved for spasticity or any condition other than glabellar lines. A forehead or crow’s feet treatment with Jeuveau is off-label.

How effective was Jeuveau in its trials?

Its two trials reported 68% and 70% of patients achieving a two-grade improvement on a four-point scale at Day 30, against a 1% placebo rate. The endpoint was unusually strict: the improvement had to be scored independently by both the investigator and the patient, and both had to agree. No trial has ever compared Jeuveau against Botox directly, so these numbers cannot be set against Botox’s.

Is Jeuveau cheaper, and does that make it better value?

Often cheaper per unit, but the comparison is not what it looks like. Both labels state that their units are set by a manufacturer-specific assay and cannot be converted into any other product’s units. A unit is not a portable measure of effect. Ask for the total price to treat your area at each clinic’s own rate, which is the only figure that compares.

How long does Jeuveau last compared with Botox?

Botox Cosmetic’s label states a duration of approximately three to four months for glabellar lines. The Jeuveau label states no duration at all. Its only timing instruction is that retreatment should be no more frequent than every three months, which is a minimum safe interval rather than a claim about when the effect fades. So one product has an approved figure and the other does not.

Sources

Every figure on this page was read from the documents below rather than from a clinic or a manufacturer's marketing. They open in a new tab so you can check any claim here against its source.